Vir Biotechnology Inc V.VIR

Primary Symbol: VIR

Healthcare Biotechnology

Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.

NDAQ:VIR - Post by User

Vir Biotechnology Inc

<< Previous

Bullboard Posts

Next >>

Post by mrwhiteduckon Mar 12, 2020 10:36am

204 Views

Post# 30798763

just passed 10 million

Wow these low prices are good for me,just bought my 10 million shares, if you know anything about this company you will know this is a great price,won,t last long,took me a long time to get to my target..nobody smart is selling as you can see by the board,JUST A FEW PEOPLE PLAYING THE GAME.i will sell next year at $1 buck.better get in now if you can..,did you hear.?

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program